Homeopathy for Prevention of Atrial Fibrillation After Aortocoronary Bypass Surgery

Phase 4TerminatedNCT00861237

Medical University of Vienna12 enrolled

Overview

After heart surgery, about 30% of patients suffer from atrial fibrillation. Patients are randomized into two groups receiving either potentized Strychnos Nux vomica or placebo under double blind conditions. Postoperatively, ECGs are done to monitor cardiac rhythm.

Preoperatively, patients receive potentized Nux vomica or placebo sublingually. Then, patients are observed regarding atrial fibrillation postsurgical. The difference between the group of patients with and without nux vomica is recorded.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Enrollment

Conditions

Atrial Fibrillation

Interventions

Nux vomica (active comparator)DRUG

Patients receive Nux vomica in a homeopathic potentiation

Placebo (placebo comparator)DRUG

Patients receive Placebo looking similar to active drug

Eligibility

Sex: ALLMin age: 18 YearsMax age: 100 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients before elective Heart valve - or aortocoronary by pass surgery with heart-lung-machine. Exclusion Criteria: * Pregnant patients * Patients with preoperative atrial fibrillation and/or hyperthyreosis

Locations (1)

Dept Surgery, Med Univ Vienna

Vienna, Austria

Outcomes

Primary Outcomes

Frequency of atrial fibrillation after heart surgery with heart lung machine

Time frame: 24 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.